1. Home
  2. Analysis
  3. Cosopt
  4. Scopolamine

Cosopt and Scopolamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Cosopt and Scopolamine together.

The phase IV clinical study analyzes what interactions people who take Cosopt and Scopolamine have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 24, 2023

3 people who take Cosopt and Scopolamine together, and have interactions are studied.

What is Cosopt?

Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 8,369 Cosopt users for its effectiveness, alternative drugs and more.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 3,733 Scopolamine users for its effectiveness, alternative drugs and more.

Number of Cosopt and Scopolamine reports submitted per year:

Cosopt and Scopolamine drug interactions.

Common Cosopt and Scopolamine drug interactions by gender *:

female:

  1. Back pain
  2. Benign neoplasm of adrenal gland
  3. Blindness
  4. Bone disorder
  5. Bronchitis
  6. Bruxism
  7. Cataract
  8. Central nervous system lesion
  9. Cholelithiasis
  10. Confusional state

male:

  1. Angle closure glaucoma

Common Cosopt and Scopolamine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Angle closure glaucoma

40-49:

n/a

50-59:

  1. Cough
  2. Death
  3. Decreased interest
  4. Delusion
  5. Device related infection
  6. Diplopia
  7. Dizziness
  8. Dry eye
  9. Dry mouth
  10. Dysphagia

60+:

  1. Abdominal distension
  2. Amaurosis fugax
  3. Blindness
  4. Bone disorder
  5. Bone pain
  6. Bronchitis
  7. Bruxism
  8. Cataract
  9. Central nervous system lesion
  10. Cholelithiasis

* Approximation only. Some reports may have incomplete information.

Do you take Cosopt and Scopolamine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cosopt and Scopolamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cosopt side effects:

Browse all side effects of Cosopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Scopolamine side effects:

Browse all side effects of Scopolamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cosopt interactions:

Browse all interactions between Cosopt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Scopolamine interactions:

Browse all interactions between Scopolamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dorzolamide hydrochloride; timolol maleate and scopolamine (the active ingredients of Cosopt and Scopolamine, respectively), and Cosopt and Scopolamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cosopt and Scopolamine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.